Us Bancorp \De\ Teva Pharmaceutical Industries LTD Transaction History

Us Bancorp \De\

  • $75.6 Billion
  • Q4 2024

A detailed history of Us Bancorp \De\ transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Us Bancorp \De\ holds 10,156 shares of TEVA stock, worth $168,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,156
Previous 9,632 5.44%
Holding current value
$168,894
Previous $173,000 28.9%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025
BUY
$16.43 - $22.77 $8,609 - $11,931
524 Added 5.44%
10,156 $223,000
Q3 2024

Oct 28, 2024
SELL
$15.81 - $18.96 $211,917 - $254,139
-13,404 Reduced 58.19%
9,632 $173,000
Q2 2024

Aug 06, 2024
BUY
$12.78 - $17.4 $189,731 - $258,320
14,846 Added 181.27%
23,036 $374,000
Q1 2024

May 07, 2024
BUY
$10.67 - $14.43 $46,542 - $62,943
4,362 Added 113.95%
8,190 $115,000
Q4 2023

Feb 09, 2024
BUY
$8.12 - $10.63 $8,306 - $10,874
1,023 Added 36.47%
3,828 $39,000
Q3 2023

Nov 03, 2023
BUY
$7.48 - $10.7 $7,330 - $10,486
980 Added 53.7%
2,805 $28,000
Q2 2023

Aug 09, 2023
SELL
$7.2 - $9.47 $59,724 - $78,553
-8,295 Reduced 81.97%
1,825 $13,000
Q1 2023

May 09, 2023
SELL
$8.36 - $11.37 $3,569 - $4,854
-427 Reduced 4.05%
10,120 $89,000
Q4 2022

Feb 13, 2023
SELL
$7.95 - $9.48 $1,256 - $1,497
-158 Reduced 1.48%
10,547 $96,000
Q3 2022

Oct 27, 2022
BUY
$6.86 - $11.95 $3,505 - $6,106
511 Added 5.01%
10,705 $87,000
Q2 2022

Aug 01, 2022
SELL
$7.38 - $10.4 $8,405 - $11,845
-1,139 Reduced 10.05%
10,194 $77,000
Q1 2022

May 11, 2022
SELL
$7.33 - $9.39 $2,675 - $3,427
-365 Reduced 3.12%
11,333 $106,000
Q4 2021

Feb 11, 2022
BUY
$7.9 - $10.19 $1,437 - $1,854
182 Added 1.58%
11,698 $94,000
Q3 2021

Nov 10, 2021
SELL
$8.38 - $10.18 $8,304 - $10,088
-991 Reduced 7.92%
11,516 $112,000
Q2 2021

Aug 05, 2021
SELL
$9.9 - $11.56 $19,404 - $22,657
-1,960 Reduced 13.55%
12,507 $124,000
Q1 2021

Apr 28, 2021
SELL
$10.34 - $12.81 $16,016 - $19,842
-1,549 Reduced 9.67%
14,467 $167,000
Q4 2020

Feb 04, 2021
SELL
$8.61 - $11.04 $1,722 - $2,208
-200 Reduced 1.23%
16,016 $155,000
Q3 2020

Nov 10, 2020
SELL
$8.57 - $12.69 $23,850 - $35,316
-2,783 Reduced 14.65%
16,216 $146,000
Q2 2020

Aug 07, 2020
SELL
$8.12 - $13.12 $4,181 - $6,756
-515 Reduced 2.64%
18,999 $234,000
Q1 2020

May 13, 2020
BUY
$6.69 - $13.45 $51,887 - $104,318
7,756 Added 65.96%
19,514 $175,000
Q4 2019

Feb 04, 2020
SELL
$6.53 - $10.72 $17,546 - $28,804
-2,687 Reduced 18.6%
11,758 $115,000
Q3 2019

Nov 08, 2019
SELL
$6.16 - $9.6 $76,704 - $119,539
-12,452 Reduced 46.3%
14,445 $99,000
Q2 2019

Aug 13, 2019
SELL
$8.12 - $15.72 $146,655 - $283,918
-18,061 Reduced 40.17%
26,897 $248,000
Q1 2019

May 08, 2019
SELL
$15.58 - $20.01 $1.23 Million - $1.58 Million
-79,135 Reduced 63.77%
44,958 $705,000
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $609,964 - $996,678
-41,807 Reduced 25.2%
124,093 $1.91 Million
Q3 2018

Nov 01, 2018
BUY
$21.06 - $25.65 $369,160 - $449,618
17,529 Added 11.81%
165,900 $3.57 Million
Q2 2018

Aug 08, 2018
BUY
$16.77 - $24.71 $1.69 Million - $2.48 Million
100,518 Added 210.06%
148,371 $3.61 Million
Q1 2018

May 08, 2018
SELL
$16.68 - $22.07 $53,059 - $70,204
-3,181 Reduced 6.23%
47,853 $818,000
Q4 2017

Feb 02, 2018
SELL
$11.23 - $19.1 $340,695 - $579,455
-30,338 Reduced 37.28%
51,034 $968,000
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $1.25 Million - $2.62 Million
81,372
81,372 $1.43 Million

Others Institutions Holding TEVA

# of Institutions
658
Shares Held
579M
Call Options Held
17.5M
Put Options Held
8.11M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $18.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email